Kristin M. Bircsak
Papers
1
Total Citations
176
H-Index
1
About
Kristin M. Bircsak is a leading figure in the development of advanced in vitro models for drug safety assessment, with a primary focus on hepatotoxicity and microphysiological systems. Her most impactful work centers on the creation of the OrganoPlate® LiverTox™, a 3D microfluidic liver-on-a-chip platform that enables high-throughput compound toxicity screening. This groundbreaking model, detailed in her highly cited 2021 paper (176 citations), utilizes aggregates of induced pluripotent stem cell (iPSC)-derived hepatocytes (iHep) embedded in an extracellular matrix, offering a physiologically relevant alternative to traditional 2D cultures. Bircsak’s contributions have significantly advanced the field by demonstrating the automation and validation of this platform, making it a practical tool for preclinical drug development. Her research bridges the gap between stem cell biology and tissue engineering, providing a scalable solution for predicting human liver toxicity. With her work cited extensively, Bircsak has established herself as a key innovator in organ-on-a-chip technology, driving the adoption of more ethical and accurate methods in pharmaceutical safety testing.
Research Focus
Key Achievements
Top Papers
- 1